Number of the records: 1  

CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis

  1. 1.
    0350375 - MBÚ 2011 RIV US eng J - Journal Article
    Richter, Jan - Benson, Veronika - Grobárová, Valeria - Svoboda, Jan - Vencovský, J. - Svobodová, R. - Fišerová, Anna
    CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis.
    Clinical Immunology. Roč. 136, č. 1 (2010), s. 139-147. ISSN 1521-6616. E-ISSN 1521-7035
    R&D Projects: GA ČR GA310/06/0477; GA ČR GD310/08/H077; GA MZd NR9106; GA AV ČR IAA500200620
    Institutional research plan: CEZ:AV0Z50200510
    Keywords : Rheumatoid arthritis * NK cells * CD161
    Subject RIV: EC - Immunology
    Impact factor: 3.932, year: 2010

    Permanent Link: http://hdl.handle.net/11104/0190392
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.